Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abiomed Inc (NQ: ABMD )

301.72 USD -1.15 (-0.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Abiomed Inc

< Previous 1 2 3 4 5 6 7 8 9
...
62 63 Next >
The Math Shows FXH Can Go To $129
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients
Abiomed (NASDAQ: ABMD) has acquired preCARDIA, developer of a proprietary catheter and controller that will complement Abiomed’s product portfolio to expand options for patients with acute... 
From Business Wire News Releases
Abiomed to Present at Upcoming Investor Conferences
Abiomed to present at William Blair’s 41st Annual Growth Stock Conference and the Jefferies Virtual Healthcare Conference. 
From Business Wire News Releases
Look Under The Hood: QQQJ Has 18% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Avoid the Dogecoin Crash by Buying These 2 Growth Stocks Instead
Dogecoin may be breaking its all-time highs every other day, but there's nothing averting a catastrophic fall. 
Tags CRSP ABMD Market News
From Motley Fool
Abiomed to Shareholders: Patience Please, Growth Is On The Way.
Despite record revenue for its latest quarter, the medical device maker's shares sank 8% following its earnings release. But its next stage of growth is coming. 
Tags EW Market News ABMD
From Motley Fool
The End of the Pandemic Will Mean a Major Boost for These 2 Buy-and-Hold Stalwarts
People will be getting back to their regular routines when it comes to medical and dental care. 
Tags Market News ABMD ALGN
From Motley Fool
Abiomed Inc (ABMD) Q4 2021 Earnings Call Transcript
ABMD earnings call for the period ending March 31, 2021. 
Tags ABMD Market News
From Motley Fool
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AMGN IRMD BPTS
From Benzinga
Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin
Abiomed announces record revenue of $241 million , up 17% year over year, with 26.0% operating margin. 
From Business Wire News Releases
Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella
The final results of the physician-led National Cardiogenic Shock Initiative (NCSI) Study demonstrate a 71% survival to discharge with greater than 90% native heart recovery when best practices are... 
From Business Wire News Releases
Dr. Paula A. Johnson Joins Abiomed Board of Directors
Dr. Paula Johnson joins the Abiomed Board of Directors 
From Business Wire News Releases
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & ... 
Tags DXCM Market News IART
From Benzinga
First Patient Enrolled in PROTECT IV Randomized Controlled Trial of Impella
Abiomed (NASDAQ:ABMD) announced today that the first patient has been enrolled in PROTECT IV, a large, prospective, multi-center randomized controlled trial (RCT) that is designed to provide the level... 
From Business Wire News Releases
3 Overlooked Healthcare Stocks to Buy Right Now
The best is yet to come for each of these companies. 
Tags ISRG BNTX PFE
From Motley Fool
Abiomed Fourth Quarter Fiscal 2021 Earnings and Conference Call Notification
Abiomed announces that on Thursday, April 29, 2021 the Company will release financial results for the fourth quarter of fiscal 2021. 
From Business Wire News Releases
Analysts Forecast 11% Upside For The Holdings of XLV
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Buy These 3 Breakout Healthcare Stocks if There's a Sell-Off or Correction
I've been waiting to buy these stocks at a better price. Now might just be the time. 
Tags ABMD Market News TDOC
From Motley Fool
Better Buy for the Next 10 Years: Abiomed vs. Guardant Heath
Which healthcare company is a better play for the next decade? 
Tags NTRA ILMN ABMD
From Motley Fool
This Company Will Fix the Hidden COVID Danger to Come
There are long-term implications to the coronavirus pandemic that the market is not appreciating. 
Tags Market News ABMD JNJ
From Motley Fool
ImmunityBio Larger Than S&P 500 Component ABIOMED
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component ImmunityBio Inc (IBRX) was identified as having a larger market cap than the smaller end of the S&P 500,... 
Tags Stocks
From Market News Video
Notable Friday Option Activity: RUTH, CAL, ABMD
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Ruth's Hospitality Group Inc (RUTH), where a total of 2,487 contracts have traded so far,... 
Tags Stocks
From Market News Video
Could Abiomed Be a Millionaire-Maker Stock?
This medical device company has revenue growth, patents, and a bright outlook. 
Tags ABMD Market News
From Motley Fool
Relative Strength Alert For ABIOMED
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
ABIOMED Breaks Below 200-Day Moving Average - Notable for ABMD
In trading on Friday, shares of ABIOMED, Inc. (ABMD) crossed below their 200 day moving average of $284.77, changing hands as low as $282.23 per share.. 
Tags Stocks
From Market News Video
LRGF's Holdings Could Mean 11% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Stocks With Rising Relative Strength: Abiomed
A Relative Strength Rating upgrade for Abiomed shows improving technical performance. Will it continue? 
From Investor's Business Daily
Abiomed Announces Appointment of Dr. Myron Rolle to Board of Directors
Abiomed announces the appointment of Myron Rolle, MD, to the Abiomed Board of Directors. 
From Business Wire News Releases
Abiomed to Present at Upcoming Investor Conferences
Abiomed to present at upcoming investor conferences. 
From Business Wire News Releases
Where to Invest $10,000 Right Now
These stocks were successful last year -- and the future looks even brighter. 
Tags ABT Market News ABMD
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
62 63 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.